Kimberly D Siegmund

Title: The Innovative Contributions of Kimberly D. Siegmund

Introduction

Kimberly D. Siegmund is a prominent inventor based in San Marino, CA (US). She has made significant contributions to the field of medical diagnostics, particularly in the area of bladder cancer. With a total of 4 patents to her name, her work is paving the way for advancements in cancer prediction and prognosis.

Latest Patents

Among her latest patents, Kimberly has developed methods utilizing DNA methylation biomarkers for bladder cancer. These methods focus on the prediction, prognosis, and diagnosis of bladder cancer or its recurrence in patients. The process involves providing a test sample from the subject, measuring DNA methylation levels of specific polynucleotides, calculating a risk score, and comparing it to a reference DNA methylation profile. This innovative approach allows for determining whether bladder cancer has recurred, the likelihood of recurrence, or if the patient currently has bladder cancer.

Career Highlights

Kimberly D. Siegmund is affiliated with the University of Southern California, where she continues her research and development in medical diagnostics. Her work is characterized by a commitment to improving patient outcomes through innovative technologies.

Collaborations

Some of her notable coworkers include Peter A. Jones and Sheng-Fang Su, who contribute to her research endeavors and collaborative projects.

Conclusion

Kimberly D. Siegmund's innovative work in the field of bladder cancer diagnostics exemplifies the impact of research and invention on healthcare. Her contributions are vital in advancing medical technology and improving patient care.